A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activation. Issue 10 (9th October 2020)

• Record Type: Journal Article
• Authors: Kerr, Sheena C; Morgan, Molly M; Gillette, Amani A; Livingston, Megan K; Lugo-Cintron, Karina M; Favreau, Peter F; Florek, Logan; Johnson, Brian P; Lang, Joshua M; Skala, Melissa C; Beebe, David J
• Is Part Of: Integrative biology. Volume 12:Issue 10(2020)
• Page Start: 250
• Page End: 262
• Publication Date: 2020-10-09
• Subjects: Biology -- Periodicals; Technology -- Periodicals; Biological systems -- Periodicals; 570.5
• DOI: 10.1093/intbio/zyaa020
• Languages: English
• ISSNs: 1757-9694

Abstract

Abstract: The prostate tumor microenvironment (TME) is strongly immunosuppressive; it is largely driven by alteration in cell phenotypes (i.e. tumor-associated macrophages and exhausted cytotoxic T cells) that result in pro-tumorigenic conditions and tumor growth. A greater understanding into how these altered immune cell phenotypes are developed and could potentially be reversed would provide important insights into improved treatment efficacy for prostate cancer. Here, we report a microfluidic model of the prostate TME that mimics prostate ducts across various stages of prostate cancer progression, with associated stroma and immune cells. Using this platform, we exposed immune cells to a benign prostate TME or a metastatic prostate TME and investigated their metabolism, gene and cytokine expression. Immune cells exposed to the metastatic TME showed metabolic differences with a higher redox ratio indicating a switch to a more glycolytic metabolic profile. These cells also increased expression of pro-tumor response cytokines that have been shown to increase cell migration and angiogenesis such as Interleukin-1 (IL-1) a and Granulocyte-macrophage colony-stimulating factor (GM-CSF). Lastly, we observed decreased TLR, STAT signaling and TRAIL expression, suggesting that phenotypes derived from exposure to the metastatic TME could have an impaired anti-tumor response. This platform could provide a valuable tool for studying immune cell phenotypes in in vitro tumor microenvironments.